DeepSeek R1 is now live with privacy-first approach
Perplexity AI Unleashes Open-Source DeepSeek on iOS and Web
Perplexity AI has just launched the Chinese open‑source AI model, DeepSeek R1, on its iOS and web platforms. Safeguarding user data, the model is hosted on US‑based servers, leading to an uncensored yet secure experience. With a Perplexity Pro subscription set at $20 a month, users can explore its capabilities, although Android enthusiasts will have to wait a bit longer.
Introduction to DeepSeek R1 Integration
Ensuring Data Privacy and Preventing Censorship
Subscription and Access Details
Platform Availability and Future Expansion Plans
DeepSeek R1's Advantages in the AI Landscape
Data Privacy Assurance with Perplexity AI
Timeline for Android Support and Current Access Options
Impact of DeepSeek on the AI Industry
Challenges Posed by Chinese‑Origin Models
Cost‑Effectiveness and Global Collaboration Potential
Public Concerns and Skepticism
Future Impacts on the AI Market and Geo‑Political Dynamics
Changing Data Privacy Standards
Evolving Public Trust and Censorship Concerns
Move Towards Open‑Source AI Development
New Industry and Business Model Trends
Related News
Apr 27, 2026
China Blocks Meta's $2 Billion Manus Acquisition Amid AI Tensions
China's National Development and Reform Commission has blocked Meta's $2 billion acquisition of Manus, citing concerns over foreign investment and tech export controls. The move adds to the ongoing US-China tech tension, even as Manus relocated to Singapore and claimed significant revenue and AI capabilities.
Apr 24, 2026
Why AI Won't Rattle Apple's iPhone Ecosystem: Perplexity CEO Weighs In
Perplexity CEO Aravind Srinivas dismisses AI's potential to disrupt Apple's iPhone, citing three core advantages: digital passport, Apple Silicon, and brand trust.
Apr 24, 2026
AI Missteps in Healthcare: Lessons From Benjamin Riley's Story
Benjamin Riley's recount of his father's reliance on a flawed AI-generated medical report highlights the dangers of AI in healthcare. Dr. Adam Kittai and Dr. David Bond reveal the report was "nonsense," posing fatal risks. AI's misguided advice emphasizes the need for cautious AI applications, especially in medical circumstances.